UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy

Nature cell biology, 2020-09, Vol.22 (9), p.1064-1075

2020

Volltextzugriff (PDF)

Light-induced control of protein destruction by opto-PROTAC

Science advances, 2020-02, Vol.6 (8), p.eaay5154

2020

Volltextzugriff (PDF)

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2012-09, Vol.56 (3), p.1004-1014

2012

Volltextzugriff (PDF)

Recent Advances of Degradation Technologies Based on PROTAC Mechanism

Biomolecules (Basel, Switzerland), 2022-09, Vol.12 (9), p.1257

2022

Volltextzugriff (PDF)

Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy

Frontiers in immunology, 2024-07, Vol.15, p.1431211

2024

Volltextzugriff (PDF)

Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms

PloS one, 2014-03, Vol.9 (3), p.e91606-e91606

2014

Volltextzugriff (PDF)

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest

Cancer letters, 2011-11, Vol.310 (2), p.160-169

2011

Volltextzugriff (PDF)

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

Cancer biology & therapy, 2010-04, Vol.9 (7), p.554-561

2010

Volltextzugriff (PDF)

CNNArginineMe: A CNN structure for training models for predicting arginine methylation sites based on the One-Hot encoding of peptide sequence

Frontiers in genetics, 2022-10, Vol.13, p.1036862-1036862

2022

Volltextzugriff (PDF)

Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2―M Transition Genes

Cancer research (Chicago, Ill.), 2014-03, Vol.74 (5), p.1452-1462

2014

Volltextzugriff (PDF)

FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy

Frontiers in oncology, 2023-03, Vol.13, p.1147239-1147239

2023

Volltextzugriff (PDF)

Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion

Frontiers in immunology, 2023-06, Vol.14, p.1189953-1189953

2023

Volltextzugriff (PDF)

Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway

Marine drugs, 2014-09, Vol.12 (9), p.5072-5088

2014

Volltextzugriff (PDF)

Lactylation: Linking the Warburg effect to DNA damage repair

Cell metabolism, 2024-08, Vol.36 (8), p.1637-1639

2024

Volltextzugriff (PDF)

Potent Antitumor Activity in Experimental Hepatocellular Carcinoma by Adenovirus-Mediated Coexpression of TRAIL and shRNA against COX-2

Clinical cancer research, 2010-07, Vol.16 (14), p.3696-3705

2010

Volltextzugriff (PDF)

MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways

Cancer letters, 2016-02, Vol.371 (2), p.171-181

2016

Volltextzugriff (PDF)

The interplay of the circadian clock and metabolic tumorigenesis

Trends in cell biology, 2024-09, Vol.34 (9), p.742-755

2024

Volltextzugriff (PDF)

Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function

Nature cell biology, 2023-05, Vol.25 (5), p.714-725

2023

Volltextzugriff (PDF)

Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance

Cancer letters, 2021-11, Vol.520, p.243-254

2021

Volltextzugriff (PDF)

Eugenol protects cells against oxidative stress via Nrf2

Experimental and therapeutic medicine, 2021-02, Vol.21 (2), Article 107

2021

Volltextzugriff (PDF)

The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation

Proceedings of the National Academy of Sciences - PNAS, 2023-04, Vol.120 (15), p.e2209435120-e2209435120

2023

Volltextzugriff (PDF)

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

Thoracic cancer, 2018-07, Vol.9 (7), p.761-768

2018

Volltextzugriff (PDF)

Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity

International immunopharmacology, 2019-05, Vol.70, p.498-503

2019

Volltextzugriff (PDF)

Fructose and fructose kinase in cancer and other pathologies

Journal of genetics and genomics, 2021-07, Vol.48 (7), p.531-539

2021

Volltextzugriff (PDF)

Base editing of the mutated TERT promoter inhibits liver tumor growth

Hepatology (Baltimore, Md.), 2024-06, Vol.79 (6), p.1310-1323

2024

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Complete Springer Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(47)
Humans
(29)
Oncology
(20)
Animals
(15)
Cell Line, Tumor
(11)
Apoptosis
(10)
Mice
(10)
Cancer
(9)
Cell Biology
(8)
Kinases
(8)
Liver Cancer
(8)
Liver Neoplasms - Pathology
(8)
Proteins
(8)
Carcinoma, Hepatocellular - Genetics
(7)
Carcinoma, Hepatocellular - Pathology
(7)
Tumors
(7)
Biochemistry & Molecular Biology
(6)
Cell Proliferation
(6)
Drug Resistance
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy

Light-induced control of protein destruction by opto-PROTAC

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

Recent Advances of Degradation Technologies Based on PROTAC Mechanism

Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy

Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

CNNArginineMe: A CNN structure for training models for predicting arginine methylation sites based on the One-Hot encoding of peptide sequence

Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2―M Transition Genes

FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy

Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion

Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway

Lactylation: Linking the Warburg effect to DNA damage repair

Potent Antitumor Activity in Experimental Hepatocellular Carcinoma by Adenovirus-Mediated Coexpression of TRAIL and shRNA against COX-2

MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways

The interplay of the circadian clock and metabolic tumorigenesis

Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function

Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance

Eugenol protects cells against oxidative stress via Nrf2

The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity

Fructose and fructose kinase in cancer and other pathologies

Base editing of the mutated TERT promoter inhibits liver tumor growth

Aktive Filter

Suchergebnisse filtern